| 股东名称 | 职务 | 总持股数量（股） | 占总股本比例 | | --- | --- | --- | --- | | 王军平 | 董事 | 272,625 | 0.22% | | 证券代码：300556 | 证券简称：丝路视觉 | 公告编号：2025-083 | | --- | --- | --- | | 债券代码：123138 | 债券简称：丝路转债 | | 丝路视觉科技股份有限公司 关于董事减持股份预披露公告 董事王军平保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有本公司股份 272,625 股（占公司总股本比例 0.22%）的董事王军平拟自本 公告披露之日起 15 个交易日后的 3 个月内（2025 年 12 月 2 日至 2026 年 2 月 27 日，窗口期不减持）以集中竞价方式减持公司股份不超 68,156 股（占公司总股本 比例 0.056%）。减持期间，公司如有派息、送股、资本公积金转增股本、配股等除 权除息事项，减持底价下限和股份数量将相应进行调整。 近日，丝路视觉 ...

Group 1 - The company Silk Road Vision announced that board member Wang Junping plans to reduce his shareholding by up to approximately 68,200 shares, which represents 0.056% of the total share capital, within three months after 15 trading days from the announcement date [1] - The reduction will be conducted through centralized bidding, and any adjustments to the share price or quantity will be made in the event of dividends, stock bonuses, capital reserve transfers, or other rights issues during the reduction period [1] Group 2 - The company Nohui Health is facing significant operational challenges, with multiple office locations in Hangzhou reported to be vacant and a laboratory in Beijing allegedly behind on rent payments [1] - Former employees have indicated that the issues reported are only the tip of the iceberg, suggesting deeper problems within the company [1]

| 证券代码：300556 | 证券简称：丝路视觉 | 公告编号：2025-082 | | --- | --- | --- | | 债券代码：123138 | 债券简称：丝路转债 | | 丝路视觉科技股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1、担保人：丝路视觉科技股份有限公司（以下简称"公司"或"丝路视觉"） 2、被担保人：公司全资子公司深圳市丝路蓝创意展示有限公司（以下简称 "丝路蓝"） 3、担保基本情况介绍：丝路视觉于 2025 年 11 月 7 日与广发银行股份有限 公司深圳分行签署了《最高额保证合同》，约定为丝路蓝向广发银行股份有限公 司深圳分行申请金额不超过 4,000 万元的授信额度提供连带责任保证担保。 4、公司于 2025 年 4 月 25 日召开的第五届董事会第五次会议及 2025 年 5 月 19 日召开的 2024 年年度股东大会审议通过了《关于公司为子公司提供担保额 度预计的议案》，同意自 2024 年年度股东大会审议通过后的一年，丝路视觉为丝 路蓝向银行金融机构申请总金额不超过 ...

Core Viewpoint - Silk Road Vision (300556.SZ) reported a decline in revenue and an increase in net loss for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net loss attributable to shareholders of the listed company was 123 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 133 million yuan [1] - The basic loss per share was 1.01 yuan [1]

Core Viewpoint - Silk Road Vision (300556.SZ) reported a decline in revenue and an increase in net loss for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters was 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net loss attributable to shareholders of the listed company was 123 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 133 million yuan [1] - The basic loss per share was 1.01 yuan [1]

| 证券代码：300556 | 证券简称：丝路视觉 | 公告编号：2025-081 | | --- | --- | --- | | 债券代码：123138 | 债券简称：丝路转债 | | 丝路视觉科技股份有限公司 关于不向下修正丝路转债转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、截至 2025 年 10 月 24 日，丝路视觉科技股份有限公司（以下简称"公司"） 股票（SZ.300556）已出现连续三十个交易日中至少有十五个交易日的收盘价格 低于当期转股价格的 85%的情形，触发丝路转债（123138）转股价格的向下修正 条件。 2、经公司第五届董事会第九次会议审议，决定本次不向下修正丝路转债转 股价格。同时，自本次董事会审议通过之日起至公司 2025 年年度董事会会议召 开之日，如再次触发丝路转债转股价格向下修正条件，公司亦不提出向下修正方 案。下一触发转股价格修正条件的期间从公司 2025 年年度董事会会议召开之日 后一交易日起重新起算，若再次触发丝路转债转股价格向下修正条件，届时公司 董事会将召开会议决定是否行使丝路转 ...

Group 1 - The company Silk Road Vision (SZ 300556) held its ninth board meeting of the fifth session on October 24, 2025, via telecommunication voting, discussing the proposal for the management system for senior executives' departure [1] - For the first half of 2025, Silk Road Vision's revenue composition was 99.98% from CG business and 0.02% from other businesses [1] - As of the report date, Silk Road Vision's market capitalization was 2.5 billion yuan [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - The secondary market for biomedicine is experiencing a boom, while the primary market is facing challenges in fundraising [1]

Core Viewpoint - Silk Road Vision (300556.SZ) reported a significant decline in revenue and net profit for Q3 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for Q3 2025 was 117 million yuan, representing a year-on-year decrease of 20.38% [1] - The net profit attributable to shareholders of the listed company was -42.27 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -50.43 million yuan [1]

Group 1 - The core viewpoint of the article highlights the financial performance of Silk Road Vision, indicating a decline in revenue and a significant net loss for the third quarter of 2025 [1] - For the first three quarters of 2025, the company's revenue was approximately 393 million yuan, representing a year-on-year decrease of 10.95% [1] - The net profit attributable to shareholders was a loss of approximately 123 million yuan, with basic earnings per share reflecting a loss of 1.01 yuan [1] Group 2 - As of the report, Silk Road Vision has a market capitalization of 2.5 billion yuan [2] - The article also discusses the broader context of the biopharmaceutical market in China, noting that overseas licensing has generated 80 billion US dollars this year [2] - There is a contrast presented between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [2]

丝路视觉科技股份有限公司 董事、高级管理人员离职管理制度 丝路视觉科技股份有限公司 （二）审计委员会成员辞任导致审计委员会成员低于法定最低人数，或者欠 缺会计专业人士； 董事、高级管理人员离职管理制度 （2025 年 10 月制定） 第一章 总则 第一条 为规范丝路视觉科技股份有限公司（以下简称"公司"）董事、高 级管理人员离职管理事宜，确保公司治理稳定性，维护公司和股东的权益，根据 《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司章程指引》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律、法规、规范性文件以及《丝路视觉 科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，并结合公司实 际情况，制定本制度。 第二条 本制度适用于公司董事（含独立董事）及高级管理人员（总裁、执 行副总裁、高级副总裁、副总裁、财务总监和董事会秘书）因任期届满、辞任、 被解除职务等离职情形。 第二章 离职情形与生效条件 第三条 公司董事和高级管理人员可以在任期届满前辞职，董事和高级管理 人员辞职应当向公司提交书面辞职报告，辞职报告中应说明辞 ...